Clinicopathological and 123I-FP-CIT SPECT correlations in patients with dementia
- PMID: 29560382
- PMCID: PMC5846445
- DOI: 10.1002/acn3.521
Clinicopathological and 123I-FP-CIT SPECT correlations in patients with dementia
Abstract
The relationship between clinicopathologic diagnosis and 123I-FP-CIT SPECT in 18 patients with dementia (12 with Lewy body disease) from one center in the United States was assessed. The sensitivity and specificity of abnormal 123I-FP-CIT SPECT with reduced striatal uptake on visual inspection for predicting Lewy body disease were 91.7% and 83.3%, respectively. The mean calculated putamen to occipital ratio (mPOR) based on regions of interest was significantly reduced in Lewy body disease compared to non-Lewy body disease cases (P = 0.002). In this study, abnormal 123I-FP-CIT SPECT was strongly associated with underlying Lewy body disease pathology, supporting the utility of 123I-FP-CIT SPECT in the clinical diagnosis of dementia with Lewy bodies.
Figures

Similar articles
-
The value of multimodal imaging with 123I-FP-CIT SPECT in differential diagnosis of dementia with Lewy bodies and Alzheimer's disease dementia.Neurobiol Aging. 2021 Mar;99:11-18. doi: 10.1016/j.neurobiolaging.2020.12.009. Epub 2020 Dec 15. Neurobiol Aging. 2021. PMID: 33422890 Free PMC article.
-
Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT.J Neurol Neurosurg Psychiatry. 2012 Nov;83(11):1063-70. doi: 10.1136/jnnp-2012-302577. Epub 2012 Aug 6. J Neurol Neurosurg Psychiatry. 2012. PMID: 22869921
-
Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study.Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1642-1651. doi: 10.1007/s00259-019-04324-5. Epub 2019 May 16. Eur J Nucl Med Mol Imaging. 2019. PMID: 31098748
-
123I-FP-CIT SPECT in the differential diagnosis between dementia with Lewy bodies and other dementias.J Neurol Sci. 2015 Dec 15;359(1-2):161-71. doi: 10.1016/j.jns.2015.11.004. Epub 2015 Nov 3. J Neurol Sci. 2015. PMID: 26671107 Review.
-
Biomarkers of Dementia with Lewy Bodies: Differential Diagnostic with Alzheimer's Disease.Int J Mol Sci. 2022 Jun 7;23(12):6371. doi: 10.3390/ijms23126371. Int J Mol Sci. 2022. PMID: 35742814 Free PMC article. Review.
Cited by
-
Confirmation of 123I-FP-CIT SPECT Quantification Methods in Dementia with Lewy Bodies and Other Neurodegenerative Disorders.J Nucl Med. 2020 Nov;61(11):1628-1635. doi: 10.2967/jnumed.119.239418. Epub 2020 Mar 20. J Nucl Med. 2020. PMID: 32198310 Free PMC article.
-
[Dementia with Lewy bodies: old and new knowledge - Part 1: clinical aspects and diagnostics].Nervenarzt. 2024 Apr;95(4):353-361. doi: 10.1007/s00115-023-01576-3. Epub 2023 Dec 13. Nervenarzt. 2024. PMID: 38092983 Free PMC article. Review. German.
-
Association of quantitative histopathology measurements with antemortem medial temporal lobe cortical thickness in the Alzheimer's disease continuum.Acta Neuropathol. 2024 Sep 3;148(1):37. doi: 10.1007/s00401-024-02789-9. Acta Neuropathol. 2024. PMID: 39227502 Free PMC article.
-
Nuclear Imaging in the Diagnosis of Clinically Uncertain Parkinsonian Syndromes.Dtsch Arztebl Int. 2019 Nov 1;116(44):747-754. doi: 10.3238/arztebl.2019.0747. Dtsch Arztebl Int. 2019. PMID: 31774054 Free PMC article. Review.
References
-
- Vann Jones SA, O'Brien JT. The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med. 2014;44:673–683. - PubMed
-
- McKeith I, O'Brien J, Walker Z, et al. Sensitivity and specificity of dopamine transporter imaging with 123I‐FP‐CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol 2007;6:305–313. - PubMed
-
- Colloby SJ, McParland S, O'Brien JT, et al. Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias. Brain 2012;135:2798–2808. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical